Dasher Neuroscience Holdings (ROCO:7829) Cash Flow for Dividends: NT$0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7829 Dasher Neuroscience Holdings Inc ROCO:7829
14 GF Score
Price NT$39.00
! 2 Warning Signs
View Full Analysis

What is Dasher Neuroscience Holdings Cash Flow for Dividends?

Dasher Neuroscience Holdings ROCO:7829 -2.86% 14 Cash Flow for Dividends is NT$0.00 Mil as of Dec. 2025. GuruFocus rates ROCO:7829 with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Dasher Neuroscience Holdings's cash flow for dividends for the six months ended in Dec. 2025 was NT$0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Dasher Neuroscience Holdings Cash Flow for Dividends Related Terms

Dasher Neuroscience Holdings Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Dasher Neuroscience Holdings's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dasher Neuroscience Holdings Cash Flow for Dividends Chart

Dasher Neuroscience Holdings Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
0.00 0.00 0.00 0.00

Dasher Neuroscience Holdings Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
ROCO:7829
14GF Score
Dasher Neuroscience Holdings Inc ROCO:7829
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dasher Neuroscience Holdings Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of NT$0.00 Mil mean?
Dasher Neuroscience Holdings (ROCO:7829) has a Cash Flow for Dividends of NT$0.00 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Dasher Neuroscience Holdings and its competitors.
Is Dasher Neuroscience Holdings' Cash Flow for Dividends too high?
Dasher Neuroscience Holdings' current Cash Flow for Dividends is NT$0.00 Mil. Overall, Dasher Neuroscience Holdings has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Dasher Neuroscience Holdings' Cash Flow for Dividends compare to ZTS and UTHR?
Dasher Neuroscience Holdings' Cash Flow for Dividends of NT$0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Dasher Neuroscience Holdings and its competitors. Dasher Neuroscience Holdings's current Cash Flow for Dividends is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dasher Neuroscience Holdings stock overvalued right now?
Dasher Neuroscience Holdings (ROCO:7829) has a current Cash Flow for Dividends of NT$0.00 Mil. The current Cash Flow for Dividends is NT$0.00 Mil. Dasher Neuroscience Holdings' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Dasher Neuroscience Holdings (ROCO:7829), the current Cash Flow for Dividends is NT$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dasher Neuroscience Holdings Business Description

Address Park Street, 17th Floor., No.3, Nangang District, Taipei, TWN, 115603
Yoda Pharmaceuticals Inc is a pharmaceutical company specializing in using AI technology to develop drugs targeting Central Nervous System (CNS) disorders. The group provides solutions for Neurology, Neuropsychiatry, and Cerebrovascular Disease.
14GF Score

Get the complete analysis for ROCO:7829

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$39.00
Price